Profile
AYTU TAK ZTS HLN TEVA VTRS
Company Name Aytu BioPharma, Inc. Takeda Pharmaceutical Company Limited Zoetis Inc. Haleon plc Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $18.39M $57.75B $56.15B $49.48B $39.35B $14.94B
Employees 0.10K 49.28K 13.80K 24.56K 37.00K 32.00K
CEO Joshua R. Disbrow Christophe Weber Kristin C. Peck Brian James McNamara Richard D. Francis Scott Andrew Smith
Ratings
AYTU TAK ZTS HLN TEVA VTRS
Quant Rating Score 1 3 3 4 3 2
Quant Rating Strong Sell Neutral Neutral Buy Neutral Sell
Trading
AYTU TAK ZTS HLN TEVA VTRS
Last Close $1.98 $14.14 $118.8 $9.68 $24.59 $10.66
High 52 $2.65 $15.52 $178.71 $11.41 $25.83 $13.37
Low 52 $1 $12.89 $118.8 $8.73 $12.82 $7.26
Price vs. 52 Week High -25.28 % -8.89 % -33.52 % -15.16 % -4.8 % -20.27 %
Price vs. 52 Week Low 98 % 9.7 % 0 % 10.88 % 91.81 % 46.83 %
Total Return
AYTU TAK ZTS HLN TEVA VTRS
1 Month Return -13.54 % 0.71 % -17.53 % 2.11 % 27.34 % 4.82 %
3 Month Return -10 % -6.73 % -21.96 % -0.05 % 36.16 % 0.28 %
6 Month Return -7.04 % 0.21 % -27.13 % -10.37 % 45.16 % 20.59 %
9 Month Return 41.43 % 1.73 % -24.08 % -3.1 % 48.4 % -1.84 %
YTD Return 16.47 % 6.8 % -27.09 % 1.47 % 11.57 % -14.38 %
1 Year Return 24.13 % 3.82 % -32.33 % 2.11 % 46.28 % -18.31 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AYTU TAK ZTS HLN TEVA VTRS
Dividend Yield Percentage (TTM) - 3.53 % 1.59 % 1.41 % - 3.7 %
Dividend Paid and Capex Coverage Ration (TTM) -5.78 % 2.23 % 1.89 % 2.01 % 4 % 2.09 %
Dividend Per Share (TTM) - 198 % 2.03 % 0.06 % - 0.48 %
Payout Ratio (TTM) - 277.04 % 32.55 % 27.27 % - -15.34 %
Profitability
AYTU TAK ZTS HLN TEVA VTRS
Gross Profit Margin TTM 66 % 59.49 % 70.63 % 61.81 % 51.76 % 36.07 %
Return on Assets TTM -20.04 % 0.73 % 17.49 % 4.78 % 3.48 % -9.73 %
Return on Equity TTM -107.16 % 1.58 % 53.56 % 9.4 % 20.09 % -22.69 %
Return on Capital Employed TTM -15.37 % 3.59 % 26.48 % 8.34 % 11.54 % -8.43 %
Net Income Per EBT TTM 100.82 % 54.99 % 79.59 % 76.52 % 114.62 % 95.92 %
EBT Per Ebit TTM 279.44 % 44.75 % 94.2 % 88.09 % 39.3 % 149.32 %
EBIT Per Revenue TTM -13.85 % 10.28 % 37.63 % 20.49 % 18.15 % -18.25 %
Cash Flow To Debt Ratio TTM -2.58 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Receivables Turnover TTM 2.03 5.89 6.1 5.14 4.68 3.94
Payables Turnover TTM 1.49 3.87 6.73 1.18 3.31 6.81
Inventory Turnover TTM 2.46 1.29 1.12 3.72 2.63 2.2
Fixed Asset Turnover TTM 4340.96 % 214.23 % 241.44 % 589.57 % 392.13 % 488.38 %
Asset Turnover TTM 51.34 % 28.97 % 61.99 % 34.62 % 42.58 % 37.25 %
Operating Cash Flow Per Share TTM -0.06 710.55 6.58 0.11 1.76 1.7
Free Cash Flow Per Share TTM -0.07 589.53 5.06 0.1 1.32 1.37
Cash Per Share TTM 299.16 % 48236.45 % 470.54 % 7.46 % 309.55 % 99.36 %
Operating Cash Flow Sales Ratio TTM -0.95 % 25.14 % 31.03 % 9.32 % 11.64 % 14.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 117.31 % 82.97 % 76.82 % 90.65 % 74.99 % 80.65 %
Cash Flow Coverage Ratios TTM -2.58 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Price To Free Cash Flows Ratio TTM -26.34 9.51 25.07 38.08 26.14 9.34
Price To Operating Cash Flows Ratio TTM -38.29 7.89 19.35 35.1 19.64 7.62
Price Cash Flow Ratio TTM -38.29 7.89 19.35 35.1 19.64 7.62
Income Statement (TTM)
AYTU TAK ZTS HLN TEVA VTRS
Revenue $0.07B $4581.55B $9.26B $11.23B $17.26B $14.74B
Gross Profit $0.05B $3001.33B $6.4B $6.95B $8.94B $5.62B
Gross Profit Ratio 69.04% 65.51% 69.1% 61.85% 51.79% 38.15%
EBITDA $-0B $1210.51B $3.87B $2.51B $3.14B $2.82B
Net Income $-0.01B $107.93B $2.49B $1.44B $1.41B $-0.63B
EPS Diluted -2.16 33.62 5.47 0.32 1.2 -0.53
Balance Sheet (MRQ)
AYTU TAK ZTS HLN TEVA VTRS
Long Term Debt $0.01B $3966.33B $5.39B $8.62B $15.56B $14.22B
Total Liabilities $0.11B $7312.37B $9.47B $18.09B $32.83B $22.87B
Total Equity $0.02B $6935.98B $4.77B $16.22B $7.91B $18.64B
Total Investments $0B $382.4B $0.03B $0.14B $0B $1.7B
Total Debt $0.02B $4515.27B $6.74B $10.1B $17.38B $14.31B
Total Assets $0.12B $14248.34B $14.24B $34.32B $40.75B $41.5B
Cash Flow Statement (TTM)
AYTU TAK ZTS HLN TEVA VTRS
Net Income $-0.01B $107.93B $2.5B $1.44B $1.42B $-0.63B
Inventory $0B $-34.97B $-0.04B $0.22B $0.15B $-0.72B
Dividends Paid $0B $-302.5B $-0.79B $-0.57B $0B $-0.57B
Operating Cash Flow $-0B $1057.18B $2.95B $2.3B $1.65B $2.3B
Capital Expenditure $-0B $-200.8B $-0.66B $-0.25B $-0.5B $-0.33B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 3.365
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 0.86
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 4.6894
ALVOW Alvotech 0.4
AMPH Amphastar Pharmaceuticals, Inc. 27.8699
AMRX Amneal Pharmaceuticals, Inc. 14.7
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 76.02
APUS Apimeds Pharmaceuticals US, Inc 1.24
AQST Aquestive Therapeutics, Inc. 3.76
ASRT Assertio Holdings, Inc. 11.655
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 21.64
ETFs With Exposure to AYTU
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00002 337.395
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00001 149.58
VXF Vanguard Extended Market Index Fund 0.00019 213.775
VUN.TO Vanguard U.S. Total Market Index ETF 0.00002 124.97
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00002 117.07
PQSV PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Value ETF 0.1 66.2468
VGRO.TO Vanguard Growth ETF Portfolio 0.00001 44.02
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00001 55.24
VBAL.TO Vanguard Balanced ETF Portfolio 0.00001 37.66
VCNS.TO Vanguard Conservative ETF Portfolio 0 32.02
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.33
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 26.95
DFAT Dimensional U.S. Targeted Value ETF 0.00000354 65.66
DFAS Dimensional U.S. Small Cap ETF 0.0000752 74.845
DFAC Dimensional U.S. Core Equity 2 ETF 0.0000058 40.775
VTSAX Vanguard Total Stock Market Index Fund 0.00002 166.24
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00019 165.55
VITSX Vanguard Total Stock Market Index Fund 0.00002 166.27
DFSU Dimensional US Sustainability Core 1 ETF 0.00057067 43.47
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00019 165.56
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKL iShares Morningstar Small-Cap Value ETF 0 172.726
VTS.AX Vanguard US Total Market Shares Index ETF 0.00002 484.72
DCOR Dimensional ETF Trust 0.0001881 75.565
VEMPX Vanguard Extended Market Index InstlPlus 0.00019 408.54
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00002 311.9
Unlock